Mouse Models of Cancer Study
Antigens Involved in Adaptive Immunity
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Peter J Matulich1, Carly N Sprague1, Victoria P Schuster1
1Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR, USA.
Comparing neoantigens in cancer immunotherapy is crucial. Peptide-MHC complex stability, not binding affinity, better predicts the effectiveness of cytotoxic CD8+ T cell responses in preclinical models.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: